跳至主要内容
临床试验/NCT05345574
NCT05345574Unknown不适用

The Effect of Dexmedetomidine and Remifentanil Infusion on Postoperative Sore Throat After Lumbar Spine Surgery in the Prone Position

Yeungnam University College of Medicine1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2018年12月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
104
试验地点
1
主要终点
incidence of postoperative sore throat at rest

研究概览

简要总结

This study was performed to compare the effect of dexmedetomidine and remifentanil on the incidence and severity of postoperative sore throat in patients undergoing spinal surgery in the prone position who are at risk of developing postoperative sore throat.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status classification I and II
  • Undergoing lumbar spine surgery in prone position

排除标准

  • Pre-existing sore throat, hoarseness, or upper respiratory tract infection
  • Allergy to the study drugs
  • Anticipated difficult airways
  • More than two attempts at intubation

研究组 & 干预措施

dexmedetomidine infusion group

Active Comparator

dexmedetomidine infusion (loading dose of 1 ㎍/kg over 10 min and continuous infusion of 0.3-0.6 ㎍/kg/h) during the surgery

干预措施: dexmedetomidine infusion (Drug)

remifentanil infusion group

Active Comparator

remifentanil of 0.05 ㎍/kg/h during induction, followed by remifentanil infusion (0.05-0.3 ㎍/kg/h) during the surgery

干预措施: remifentanil infusion (Drug)

结局指标

主要结局

incidence of postoperative sore throat at rest

时间窗: 1 hour after surgery

0=none; 1=occur

incidence of postoperative sore throat at swallowing

时间窗: 1 hour after surgery

0=none; 1=occur

severity of postoperative sore throat at rest

时间窗: 1 hour after surgery

4-point scale (0=none; 1=mild; 2=moderate; 3=severe)

severity of postoperative sore throat at swallowing

时间窗: 1 hour after surgery

4-point scale (0=none; 1=mild; 2=moderate; 3=severe)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eun Kyung Choi

Professor

Yeungnam University College of Medicine

研究点 (1)

Loading locations...

相似试验